What Is the Future of the Procalcitonin Antibody Market? 2025–2032 Outlook According to a newly published market research report by 24LifeSciences, global procalcitonin antibody market was valued at USD 280 million in 2024 and is projected to reach USD 450 million by 2032, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 2025–2032. Procalcitonin (PCT), a 116-amino acid peptide precursor to the hormone calcitonin, has become a cornerstone biomarker in clinical diagnostics. Procalcitonin antibodies are highly specific immunoglobulins essential for developing immunoassays that accurately quantify PCT levels in patient serum. This measurement is clinically vital for the differential diagnosis of bacterial versus viral infections, effectively guiding antibiotic therapy decisions, improving patient outcomes in sepsis management, and supporting global antimicrobial stewardship initiatives in critical care settings. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11050/procalcitonin-antibody-market